GLP-1 and morning workouts: what actually changes
The most common reader question I get from people who train regularly is whether tirzepatide will tank their lifts. The honest answer is more interesting than yes or no.
The reader email I get most from people who actually train is some version of: I'm starting tirzepatide, will it kill my workouts?
The honest answer involves two different questions hiding inside one. The first is whether the drug itself impairs performance. The second is whether the calorie intake you'll likely run on the drug supports the training you were doing before. They're related and they're not the same.
What the drug does to performance directly
The acute effect of GLP-1 receptor agonism on athletic performance has been studied less than you'd think for drugs this widely used. The mechanism doesn't suggest a direct hit to muscular performance, cardiovascular capacity, or recovery. The drugs aren't catabolic. They don't compete with insulin signaling at relevant doses. There's no theoretical reason a 5mg tirzepatide injection on Sunday should make a Tuesday morning squat session feel different.
What people actually report on lifts is mixed. Some say nothing changes. Some say the first month is rough and then it normalizes. A small group reports persistent low energy.
The most consistent pattern: people who keep their protein intake at or above where it was pre-drug, and who eat enough total calories to support their training (even if they're losing weight), perform close to baseline on lifts. People who let their calorie intake drift down with their reduced appetite see performance suffer in the second and third week, then either adapt or stop training as hard.
The calorie problem
This is the part nobody emphasizes enough. The drug suppresses appetite. Your training requires fuel. If you're cutting calories meaningfully (which is the point), you have a smaller budget. The question is what you spend it on.
Most people instinctively cut total food first and protein last, but the appetite suppression makes total food easy to cut. What gets harder is hitting the protein target you need. A trained adult on tirzepatide needs roughly the same protein per kg as before; what they don't need is the same total carbohydrate. Most people end up chronically underfed on protein in the first two months unless they consciously front-load it.
The simplest rule that works: every meal starts with 30g of protein, and you eat at least three meals even if you're not hungry. Carbs slot in around the protein. If you're lifting hard, time some carbs to within an hour of training.
This isn't a tirzepatide-specific principle. It's a mild caloric deficit principle. The drug just makes it more important because the appetite signals you'd normally trust to manage protein are no longer reliable.
Cardio versus strength
Strength performance tends to be more robust to short-term caloric deficit than steady-state cardio performance. Lifters often feel close to baseline at week eight. Runners and cyclists doing hour-plus sessions feel the deficit faster.
If you're training for endurance (a half marathon, a long cycle), the first six to eight weeks on tirzepatide are not the time to hit a personal best. Aerobic adaptation is sensitive to total energy availability. Maintain volume, drop intensity slightly, accept that you're in a cut phase. After the body adjusts to the new caloric set point and weight stabilizes (usually around month four to six), aerobic performance comes back.
If you're training for strength, the first six weeks are workable. Volume holds. The set you'd normally hit hard might feel one rep harder. Your top-set weights might dip 5-10% briefly. They typically recover when food intake stabilizes.
Hydration and pre-training meals
The slowed gastric emptying that comes with the drug means a meal you used to eat 90 minutes before training might still be sitting heavily at training time. Most people end up either eating earlier (two and a half hours pre-training instead of ninety minutes) or smaller (a piece of fruit and a bit of protein, not a full meal).
Hydration matters more on the drug than it did off, partly because thirst signals are blunted and partly because losing weight quickly involves shedding water that needs replacing. Adding electrolytes to your training-day water is a small move that pays off in how the workout feels.
When to actually back off
If you're feeling worse at training in week three than you did in week one, and you've checked that your protein intake is on target, that's the body telling you to drop a dose increment or slow the ramp. Skip the next planned step-up. Stay at the current dose for an extra month.
If you're feeling lightheaded during cardio or shaky in the gym at any point, that's not a tough-it-out situation. That's an undereating signal. Eat more, train less hard, see how it feels in a week.
The drug rewards being honest with yourself about what you're putting into the system. Athletes who treat tirzepatide as a tool that needs to be fed, not a magic that runs on nothing, generally do well. The ones who try to ride the appetite suppression all the way down regret it around week six.
One email a week. Catalog updates, new posts, BKK supply state. No spam, no MLM. What lands in the inbox →
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.
Mira Tanaka is the editor at panya, based in Bangkok. Editor at Panya. Covers peptide therapeutics with a focus on the routing decisions mainstream adults actually face. Corrections, tips, or push-back: editor@panya.health.
Australia GLP-1 buyer's guide · May 2026: Juniper, Pilot, Mosh, LillyDirect, scored honestly
Three telehealth operators (Juniper, Pilot, Mosh) plus LillyDirect's direct path. TGA September 2025 advertising enforcement reset the marketing landscape. Brand-pharmacy supply only · Australia doesn't have a US-style compounded GLP-1 market. Per-month pricing, what each operator actually offers, who fits where.
The compounded vs brand decision in 90 seconds
I keep getting the same question from different friends in different cities. Here's the version short enough to get through over coffee. The decision today (May 2026) is different from the one a year ago, and the difference is mostly about what you actually want from your supply chain.
The 8-week window where most people quit a GLP-1 (and what to do instead)
A coach in Singapore told me the same thing my doctor friend in Bangkok told me: the people who quit tirzepatide almost all quit between week 6 and week 10. The reason isn't the side effects you'd guess. It's the gap between when the discomfort peaks and when the visible results start showing up.